- Alvarez-Paiva, MD, Gustavo A.
- Ayoade, MD , PhD, Katherine O.
- Bierbaum, MD, W. Frederick
- Bridge, MD, Julia A.
- Chenault, MD, FCAP, Carrie
- Czapla, MD, Aggie
- Dang, MD, Daniel N.
- Driver, MD, Brandon
- El-Zayaty, MD, Chad
- Eze, MD, MHS, Ogechukwu P.
- Hernandez, MD, Amanda K.
- Hick, MD, Ryan W.
- Hill, MD, Isabel C.
- Hosler, MD, PhD, Gregory A.
- Hu, MD, PhD, Xiaofeng
- Joldoshova, MD, Albina
- Juarez, MD , Valerie M.
- Koo, MD, Jamie
- Law, MD, Robert M.
- Lemeshev, MD, Yan H.
- Lewin, MD, Matthew
- Lewin, MD, Marc R.
- Litz, MD, Craig E.
- Luo, MD, Yehung Vivian
- Ly, DO, Uyen Debbie
- Ly, MD, Linda
- Malhotra, MD, Reenu
- Miles, MD, Janet M.
- Murphy, PhD, Kathleen M.
- O’Leary, MD, Erin
- Oliai, MD, Bahram Robert
- Onyeagocha, MD, Chukwuma O.
- Paluru, MD, Swetha
- Patel, DDS, Paras B.
- Patel, MD, Ravi A.
- Patel, MD, Kirtesh
- Peters, MD, PhD, John M.
- Podberezin, MD, PhD, Mark
- Rainwater, MD, Gina
- Roberts, MD, MBA, Cory A.
- Ruiz, MD, Monica I.
- Sarode, MD, Venetia R.
- Simms, MD, Anthony
- Smith MD, Stacey L.
- Snowden, MD, Cindi
- Susa, DO, Joseph S.
- Tumminello, MD, Katherine
- Underwood, MD, Caroline I.M.
- Vinovrski, MD, Todd J.
- Washington, MD, Paula J.
- Welter, MD, Kimberly R.
- Wu, MD, Horace C.
Brandon Driver, MD
Board Certifications
Cytopathology, Anatomic and Clinical Pathology
Fellowship
Surgical Pathology, Cytopathology
Interests
Women's Health
Biography
ProPath, a Sonic Healthcare anatomic pathology practice, is privileged to include Brandon Driver, M.D., as a part of its dynamic medical staff. Dr. Driver is a double board-certified pathologist with robust professional medical, leadership, and research experience.
Dr. Driver graduated with a Bachelor of Science degree in biochemistry from Oklahoma Christian University in Oklahoma City, OK. He earned his medical degree from the University of Texas Medical Branch in Galveston. Dr. Driver served a residency in anatomic and clinical pathology at Houston Methodist Hospital. Following his residency, he completed a fellowship in surgical pathology at the University of Arkansas for Medical Sciences in Little Rock, AR. Afterward, he completed a second fellowship in cytopathology from the same institution.
Dr. Driver has been appointed to a variety of roles throughout his career, including research positions and medical directorships. He was a research technician in the microbiology and immunology department at the University of Oklahoma Health Sciences Center. Following his postgraduate training, he was a pathologist at Jefferson Regional Medical Center in Pine Bluff, Arkansas, where he was an initiator for the Pap smear program, pathology representative on the cancer committee and presenter for the tumor board. While at Jefferson Regional Medical Center, he was also appointed to the position of cytopathology director of laboratory. Following these positions, Dr. Driver started as a pathologist at ProPath in Dallas, TX, where he has served since 2022.
Dr. Driver has an extensive list of peer-reviewed publications in prestigious medical journals in the areas of pathology and cytopathology. These include articles published in the American Journal of Clinical Pathology and Archives of Pathology and Laboratory Medicine, among others. He has also presented abstracts and poster presentations at the annual meetings of the United States and Canadian Academy of Pathology, Texas Society for Pathologists, and Oklahoma Academy of Sciences.
Dr. Driver belongs to several professional organizations. These include the American Society of Cytopathology, College of American Pathologists, and the United States and Canadian Academy of Pathology.
Dr. Driver holds full medical licensure and is board certified in cytopathology and anatomic and clinical pathology by the American Board of Pathology.
Education
Oklahoma Christian University (BS)
Oklahoma City, OK
University of Texas Medical Branch (MD)
Galveston, TX
Postgraduate Training
Cytopathology Fellowship
University of Arkansas for Medical Sciences
Little Rock, AR
Surgical Pathology Fellowship
University of Arkansas for Medical Sciences
Little Rock, AR
Anatomic and Clinical Pathology Residency
Houston Methodist Hospital
Houston, TX
Professional Memberships
American Society of Cytopathology
College of American Pathologists
United States and Canadian Academy of Pathology
Peer-Reviewed Articles
- Rosenbaum MW, Flood JG, Melanson SEF, Baumann NA, Marzinke MA, Rai AJ, Hayden J, Wu AHB, Ladror M, Lifshitz MS, Scott MG, Peck-Palmer OM, Bowen R, Babic N, Sobhani K, Giacherio D, Bocsi GT, Herman DS, Wang P, Toffaletti J, Handel E, Kelly KA, Albeiroti S, Wang S, Zimmer M, Driver B, Yi X, Wilburn C, Lewandrowski KB. Quality control practices for chemistry and immunochemistry in a cohort of 21 large academic medical centers. Am J Clin Pathol. 2018 Jul 3;150(2):96-104.
- Funkhouser WK Jr, Hayes DN, Moore DT, Funkhouser WK 3rd, Fine JP, Jo H, Nikolaishvilli-Feinberg N, Eeva M, Grilley-Olson JE, Banks PM, Graziano P, Boswell EL, Elmberger G, Raparia K, Hart CF, Sholl LM, Nolan NJ, Fritchie KJ, Pouagare E, Allen TC, Volmar KE, Biddinger PW, Kleven DT, Papez MJ, Spencer DV, Rekhtman N, Mino-Kenudson M, Hariri L, Driver B, Cagle PT. Interpathologist diagnostic agreement for non-small cell lung carcinomas using current and recent classifications. Arch Pathol Lab Med. 2018 Dec;142(12):1537-1548.
- Del C Monroig-Bosque P, Driver B, Morales-Rosado JA, Deavers M, Tacha D, Bernicker E, Cagle PT, Miller RA. Correlation between programmed death receptor-1 expression in tumor-infiltrating lymphocytes and programmed death ligand-1 expression in non-small cell lung carcinoma. Arch Pathol Lab Med. 2018 Nov;142(11):1388-1393.
- Driver BR, Miller RA, Miller T, Deavers M, Gorman B, Mody D, Ge Y, Barrios R, Bernicker E, Kim M, Cagle PT. Programmed death ligand-1 (PD-L1) expression in either tumor cells or tumor-infiltrating immune cells correlates with solid and high-grade lung adenocarcinomas. Arch Pathol Lab Med. 2017 Nov;141(11):1529-1532.
- Driver BR, Barrios R, Ge Y, Haque A, Tacha D, Cagle PT. Folate receptor α expression level correlates with histologic grade in lung adenocarcinoma. Arch Pathol Lab Med. 2016 Jul;140(7):682-5.
- Driver BR, Portier BP, Mody DR, Deavers M, Bernicker EH, Kim MP, Teh BS, Santacruz JF, Kopas L, Munden RF, Cagle PT. Next-generation sequencing of a cohort of pulmonary large cell carcinomas reclassified by World Health Organization 2015 criteria. Arch Pathol Lab Med. 2016 Apr;140(4):312-7.
- Herzig DS, Driver BR, Fang G, Toliver-Kinsky TE, Shute EN, Sherwood ER. Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock. Am J Respir Crit Care Med. 2012 Feb 1;185(3):291-300.
- Romero CD, Varma TK, Hobbs JB, Reyes A, Driver B, Sherwood ER. The Toll-like receptor 4 agonist monophosphoryl lipid an augment innate host resistance to systemic bacterial infection. Infect Immun. 2011 Sep;79(9):3576-87.
Abstracts
- Driver BR, Miller RA, Miller T, Deavers M, Tacha D, Bernicker E, Cagle PT. Correlation between programmed death-1 (PD-1) expression in tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) in non-small cell lung carcinoma. USCAP Annual Meeting, San Antonio, TX, 2017.
- Driver BR, Miller RA, Miller T, Deavers M, Gorman B, Mody D, Ge Y, Barrios R, Bernicker E, Kim M, Cagle PT [poster presented by Dr Ross Miller]. Higher PD-L1 expression correlates with solid and high-grade lung adenocarcinoma: implications for immunotherapy selection. International Association for the Study of Lung Cancer (IASLC) Annual Meeting, Vienna, Austria, 2016.
- Driver BR, Barrios R, Ge Y, Haque A, Tacha D, Cagle PT [3rd place, poster competition]. Folate receptor alpha expression level correlates with histologic grade in lung adenocarcinoma. Texas Society of Pathologists Annual Meeting, Dallas, TX, 2016.
- Driver BR. Hemolytic activity and specificity of intermedilysin undecapeptide mutants. Oklahoma Academy of Sciences Annual Meeting, Oklahoma City, OK, 2006.